Coming at a total of four genetic changes, this process is the most advanced way of curing diseases the humans have at the moment. When Cellectis began development of the treatment in 2011, they claimed they had found a way to gain control over T cells in the human body. Their efforts were shown to be a success while lab tests continuously showed more and more positive results. However, some patients don’t have enough T cells to perform this process. Seeing this as an important issue, Cellectis set out using gene editing to make a more so engineered but simpler universal supply of T cells made from the blood of donors. In conclusion, Immune Engineering has a long way to go before it hits all hospitals as the go-to cure for cancer, leukemia, and maybe even more. IT is very close to becoming a cure, but we still have years of research and tests to see how safe this process really is. With pure knowledge and science, this cure is basically right around the corner. Will this actually be the cure-all for
Coming at a total of four genetic changes, this process is the most advanced way of curing diseases the humans have at the moment. When Cellectis began development of the treatment in 2011, they claimed they had found a way to gain control over T cells in the human body. Their efforts were shown to be a success while lab tests continuously showed more and more positive results. However, some patients don’t have enough T cells to perform this process. Seeing this as an important issue, Cellectis set out using gene editing to make a more so engineered but simpler universal supply of T cells made from the blood of donors. In conclusion, Immune Engineering has a long way to go before it hits all hospitals as the go-to cure for cancer, leukemia, and maybe even more. IT is very close to becoming a cure, but we still have years of research and tests to see how safe this process really is. With pure knowledge and science, this cure is basically right around the corner. Will this actually be the cure-all for